SCHEMBL29894545

SCHEMBL29894545

N#CCc1ccnc(F)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.57
KCNQ2 O43526 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
KCNH2 Q12809 1/20 0.44
KCNH3 Q9ULD8 5/20 0.39
ENPP2 Q13822 1/20 0.38
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MMP3 P08254 1/20 0.36
FFAR1 O14842 1/20 0.36
IDO1 P14902 1/20 0.33
LRRK2 Q5S007 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL897832 1.00 LOXL2 (0.57) LOXL2KCNQ2CYP3A4ALOX15TSHR
SCHEMBL3676475 0.79 ENPP2 (0.40) LOXL2ENPP2CYP11B1CYP11B2KDM4E
SCHEMBL13183449 0.76 ENPP2 (0.38) LOXL2ENPP2CYP11B1CYP11B2KDM4E
SCHEMBL1670797 0.76 ENPP2 (0.38) LOXL2ENPP2KDM4ETDP1MMP3
SCHEMBL25673666 0.76 MYC (0.39) ENPP2CYP11B1CYP11B2KDM4ETDP1
SCHEMBL30834457 0.76 ENPP2 (0.38) LOXL2ENPP2KDM4ETDP1MMP3
SCHEMBL29841095 0.76 GRM5 (0.46) KCNQ2CYP3A4ENPP2KDM4ETDP1
SCHEMBL9280722 0.76 RECQL (0.57) LOXL2ENPP2CYP11B1CYP11B2KDM4E
SCHEMBL1925278 0.76 GRM5 (0.46) KCNQ2CYP3A4ENPP2KDM4ETDP1
SCHEMBL7375163 0.76 NOS3 (0.57) LOXL2KCNH3ENPP2KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 WO disclosed
CN-115215862-A Pyrimidone compounds and uses thereof 武汉人福创新药物研发中心有限公司 2022-10-21 CN disclosed